Post-test: Nonmelanoma Skin Cancer for Primary Care

News
Article

Find out what you've learned after reading this month's Special Report articles on nonmelanoma lesions you may see in primary care practice.

 

Question 1:


Click on links below for all sections of this Special Report, Non-melanoma Skin Cancer: A Primer for Primary Care

Part 1: Introduction and Pre-test

Part 2: A Pearly-pink Lesion on a 68-year-old Woman's Face

Part 3: Three Suspicious Lesions on an Elderly Woman's Face

Part 4: Actinic Keratosis and Squamous Cell Carcinoma: Photodamage in Progress

Part 5: A Painless, Rapidly-growing Nodule in a 74-year-old Woman

 

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Related Content
FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit ©Waldenmarus/Shutterstock.com

FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema

Grace Halsey
July 24th 2025
Article

The nonsteroidal topical pan-JAK inhibitor provides a potent treatment option for adults with CHE who have not responded to corticosteroids or cannot tolerate them.

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

The Weekly Dose: Clinical Updates on Cancer Detection, Cognitive Screening, CVD Prevention, Atopic Dermatitis Treatment

Sydney Jennings
July 8th 2025
Podcast

Discover essential clinical insights on Alzheimer disease screening in primary care, eczema treatments, and the latest in cancer detection and diet impacts on CHD risk.

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

Sydney Jennings
July 21st 2025
Article

Your daily dose of the clinical news you may have missed.

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Weekly Dose: A Roundup of Top Stories for Primary Care Physicians

Sydney Jennings
May 7th 2025
Podcast

PODCAST: Listen to our first episode for new research on bacterial vaginosis, a new treatment option for chronic urticaria, and more.

Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose / image credit: ©New Africa/AdobeStock

Lebrikizumab Found Safe, Effective in Patients With Skin of Color With AD: Daily Dose

Sydney Jennings
July 15th 2025
Article

Your daily dose of the clinical news you may have missed.

©Apogee Therapeutics

Apogee Hopes Raised by Phase 2 Data for APG777 to be a Best-In-Class for Atopic Dermatitis

Grace Halsey
July 7th 2025
Article

The investigational IL-13 inhibitor showed topline EASI-75 of 66.9% and reduced injection frequency in part A of the APEX phase 2 clinical trial.

© 2025 MJH Life Sciences

All rights reserved.